Pharmaceutical

Immatics Announces Multiple Presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on TCR-T Therapy Candidates Targeting PRAME

 Two oral presentations and multiple posters on clinical andpreclinical-stage candidates to be presented at SITC, demonstratingthe strength of Immatics’ TCR-T…

2 months ago

Teva to Present at the Jefferies London Healthcare Conference

TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that…

2 months ago

HistoIndex to Present Latest Findings on AI-based Analysis using Stain-free Digital Pathology with 12 Accepted Abstracts at AASLD The Liver Meeting® 2024

SINGAPORE, Nov. 8, 2024 /PRNewswire/ -- HistoIndex, a pioneering leader in artificial intelligence (AI) and stain-free digital pathology, will present…

2 months ago

Butterfly Network’s iQ3™ Honored as the Best Medical Technology at 2024 Prix Galien USA Awards

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--$BFLY #POCUS--Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care through the…

2 months ago

The Galien Foundation Honors 2024 Prix Galien Award Recipients

Winners received prestigious award in recognition of latest innovations in advancement in life sciences NEW YORK, Nov. 8, 2024 /PRNewswire/…

2 months ago

Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.

Facility significantly increases future financial and operational flexibilityUp to $200M available, with $30 million drawn at close and additional $80…

2 months ago

Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference

LEXINGTON, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences…

2 months ago

Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments

In-licensed ALXN-1840 (a Late-Stage Wilson Disease Drug Candidate) from Alexion, AstraZeneca Rare DiseaseTwo Novel Radiopharma Clinical Trials now Active and…

2 months ago

Shanghai thriving as global investment hub

BEIJING, Nov. 7, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn: The 2024 Shanghai City Investment Promotion Conference, held on Nov…

2 months ago

Medexus Announces Strong Fiscal Q2 2025 Results

Fiscal Q2 2025 revenue of $26.3 million, net income of $0.1 million, operating income of $1.6 million, and Adjusted EBITDA*…

2 months ago